BioMed Research International / 2014 / Article / Tab 10

Research Article

Drug Repositioning Discovery for Early- and Late-Stage Non-Small-Cell Lung Cancer

Table 10

The number of common drugs for early-stage and late-stage using the enrichment score (ES) and cMap value (less than 0.1) for meta-analysis.

Effect sizeES value
Early-stageLate-stageEarly-stageLate-stage

ES
 Early-stage0.4210.1560.136
 Late-stage160.1320.217
value < 0.1
 Early-stage550.182
 Late-stage6106